← Home / PRAXIS PRECISION MEDICINES, INC. (PRAX)
Stock Analysis
PRAXIS PRECISION MEDICINES, INC. (PRAX)
PRAX
PRAX · Market data
270.01 +4.96%
52W Range Position
73%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-06-18 13:41 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 302.81. Holding above 251.04 keeps the current thesis intact.
⚖️
Fundamentals
Weak / Insufficient
Price Structure
Mixed
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
251.04
Break Above
Confirmation improves above resistance.
302.81
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below 251.04
What's Driving PRAX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 302.81 for confirmation and 251.04 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 251.04
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
RSI(14)
42.5
How to read this setup
The nearest decision zone is framed by support around 251.09 and resistance near 302.81. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 369.52, so a violation there would materially change the current setup narrative.
Price Chart
PRAX · WOI overlay chart
Open Full Workspace
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Weak
Profitability
Insufficient
Cash Flow
Mixed
Balance Sheet
Manageable
💵 Revenue
0.00
↘ Weak
📈 Net Income
-92.56M
≈ Insufficient
🧮 EPS (Basic)
-3.20
≈ Insufficient
PRAXIS PRECISION MEDICINES, INC.
Note: This is an algorithmic technical snapshot, not financial advice.